{"id":3896,"date":"2018-10-16T11:22:58","date_gmt":"2018-10-16T09:22:58","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf"},"modified":"2018-10-16T11:22:58","modified_gmt":"2018-10-16T09:22:58","slug":"16102018_lnceng-cp-ip-cornell-20181015-002","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/lnc-therapeutics-acquires-exclusive-license-for-the-christensenella-patent-from-cornell-university\/16102018_lnceng-cp-ip-cornell-20181015-002\/","title":{"rendered":"16102018_LNCENG-CP-IP-CORNELL-20181015 (002)"},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-3896","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>16102018_LNCENG-CP-IP-CORNELL-20181015 (002) | Seventure<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf\",\"url\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf\",\"name\":\"16102018_LNCENG-CP-IP-CORNELL-20181015 (002) | Seventure\",\"isPartOf\":{\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\"},\"datePublished\":\"2018-10-16T09:22:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.seventure.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University\",\"item\":\"https:\/\/www.seventure.fr\/en\/lnc-therapeutics-acquires-exclusive-license-for-the-christensenella-patent-from-cornell-university\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"16102018_LNCENG-CP-IP-CORNELL-20181015 (002)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\",\"url\":\"https:\/\/www.seventure.fr\/en\/\",\"name\":\"Seventure\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.seventure.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"16102018_LNCENG-CP-IP-CORNELL-20181015 (002) | Seventure","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf","url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf","name":"16102018_LNCENG-CP-IP-CORNELL-20181015 (002) | Seventure","isPartOf":{"@id":"https:\/\/www.seventure.fr\/en\/#website"},"datePublished":"2018-10-16T09:22:58+00:00","breadcrumb":{"@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.seventure.fr\/en\/"},{"@type":"ListItem","position":2,"name":"LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University","item":"https:\/\/www.seventure.fr\/en\/lnc-therapeutics-acquires-exclusive-license-for-the-christensenella-patent-from-cornell-university\/"},{"@type":"ListItem","position":3,"name":"16102018_LNCENG-CP-IP-CORNELL-20181015 (002)"}]},{"@type":"WebSite","@id":"https:\/\/www.seventure.fr\/en\/#website","url":"https:\/\/www.seventure.fr\/en\/","name":"Seventure","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seventure.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf'>16102018_LNCENG-CP-IP-CORNELL-20181015 (002)<\/a><\/p>\n"},"caption":{"rendered":"<p>16102018_LNCENG-CP-IP-CORNELL-20181015 (002)<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{},"post":3893,"source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/16102018_LNCENG-CP-IP-CORNELL-20181015-002-1.pdf","_links":{"self":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media\/3896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/comments?post=3896"}]}}